ArticleMicrobiome2026
Heat stress enhances gut microbial arginine catabolism to amplify MyD88-dependent inflammatory responses.
Article in Microbiome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAs global temperatures continue to rise, heat stress (HS) has emerged as a major health threat of growing concern. HS triggers systemic inflammation and multi-organ damage, but so far its molecular mechanisms remain unclear. In this study, we explored the potential mechanism by which the gut microbial alterations amplify HS-associated inflammatory responses.
resultsWe found that the gut microbiota was disrupted in HS mice as characterized by increased LPS levels and enhanced arginine catabolism. Transplant of fecal microbiota from HS mice aggravated inflammatory responses in recipient mice after HS. Exogenous arginine pretreatment notably suppressed inflammation in the liver and cortex of HS mice. Mechanistically, arginine reduced MyD88 protein levels by activating its ubiquitination and weakened the MyD88-TLR4 interaction, thereby inhibiting the nuclear translocation of p65 and the expression of pro-inflammatory genes. Clinically, lower arginine levels were detected in the serum of HS patients and positively related with liver injury and inflammatory indicators. An arginine-enriched oral inulin hydrogel was developed to prevent inflammatory responses exacerbated by the gut microbial alterations through maintaining the gut microbiota homeostasis to reduce LPS and providing a sustained supply of arginine.
conclusionsThis study reveals a mechanism by which the gut microbial alterations exacerbates HS-associated inflammatory responses via disrupting the balance between LPS and arginine, thereby providing a novel target for the prevention of HS. Video Abstract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.